$GBCS
SELECTIS HEALTH, INC. Stock $gbcs

$gbcs Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000149315223027086 Filed on August 08, 2023

Income Statement

Concept	2023 Q1
Revenue	$9.606M
YoY Change	-4.81%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$11.14M
YoY Change	23.4%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$438.7K
YoY Change	-2.0%
% of Gross Profit
Operating Expenses	$11.58M
YoY Change	22.17%
Operating Profit	-$1.970M
YoY Change	-419.9%
Interest Expense	$518.3K
YoY Change	35.57%
% of Operating Profit
Other Income/Expense, Net	$5.996M
YoY Change	-1648.2%
Pretax Income	$4.030M
YoY Change	1662.29%
Income Tax
% Of Pretax Income
Net Earnings	$4.025M
YoY Change	1660.19%
Net Earnings / Revenue	41.9%
Basic Earnings Per Share	$1.32
Diluted Earnings Per Share	$1.32
COMMON SHARES
Basic Shares Outstanding	3.067M shares
Diluted Shares Outstanding	3.055M shares

Balance Sheet

Concept	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.160M
YoY Change	-50.32%
Cash & Equivalents	$1.157M
Short-Term Investments
Other Short-Term Assets	$7.530M
YoY Change	675.21%
Inventory
Prepaid Expenses
Receivables	$2.852M
Other Receivables	$0.00
Total Short-Term Assets	$11.54M
YoY Change	54.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$35.06M
YoY Change	-4.32%
Goodwill	$1.077M
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.040M
YoY Change	16.39%
Total Long-Term Assets	$37.18M
YoY Change	-3.71%
TOTAL ASSETS
Total Short-Term Assets	$11.54M
Total Long-Term Assets	$37.18M
Total Assets	$48.71M
YoY Change	5.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.230M
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$900.0K
YoY Change	500.0%
Long-Term Debt Due	$3.934M
YoY Change	14.39%
Total Short-Term Liabilities	$10.07M
YoY Change	32.37%
LONG-TERM LIABILITIES
Long-Term Debt	$33.38M
YoY Change	-1.42%
Other Long-Term Liabilities	$290.0K
YoY Change	23.36%
Total Long-Term Liabilities	$33.38M
YoY Change	-1.42%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.07M
Total Long-Term Liabilities	$33.38M
Total Liabilities	$43.74M
YoY Change	3.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.727M
YoY Change	-12.29%
Common Stock	$152.7K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.971M
YoY Change
Total Liabilities & Shareholders Equity	$48.71M
YoY Change	5.7%

Cashflow Statement

Concept	2023 Q1
OPERATING ACTIVITIES
Net Income	$4.025M
YoY Change	1660.19%
Depreciation, Depletion And Amortization	$438.7K
YoY Change	-2.0%
Cash From Operating Activities	-$67.00K
YoY Change	-94.42%
INVESTING ACTIVITIES
Capital Expenditures	$42.52K
YoY Change	-33.77%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$42.52K
YoY Change	-33.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$107.3K
YoY Change	-65.07%
NET CHANGE
Cash From Operating Activities	-$67.00K
Cash From Investing Activities	-$42.52K
Cash From Financing Activities	-$107.3K
Net Change In Cash	-$216.9K
YoY Change	-86.35%
FREE CASH FLOW
Cash From Operating Activities	-$67.00K
Capital Expenditures	$42.52K
Free Cash Flow	-$109.5K
YoY Change	-91.34%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000727346
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q1	GBCS	Income From Employee Retention Credits IncomeFromEmployeeRetentionCredits		usd
CY2022Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2023Q1	GBCS	Other Income From Partial Settlement Of Debt OtherIncomeFromPartialSettlementOfDebt		usd
CY2022Q1	GBCS	Other Income From Adjustment Of Debt OtherIncomeFromAdjustmentOfDebt		usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts		usd
CY2022Q1	GBCS	Increase Decrease In Employee Retention Credit Receivables IncreaseDecreaseInEmployeeRetentionCreditReceivables		usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt		usd
CY2022Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock		usd
CY2023Q1	GBCS	Proceeds From Debt Discount Warrants Related Parties ProceedsFromDebtDiscountWarrantsRelatedParties		usd
CY2022Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2022Q1	GBCS	Preferred Stock Dividends And Other Adjustments Diluted PreferredStockDividendsAndOtherAdjustmentsDiluted		usd
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock		shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock		shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	0-15415
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Selectis Health, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	UT
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0340206
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	8480 E Orchard Rd
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ste 4900
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Greenwood Village
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80111
CY2023Q1	dei	City Area Code CityAreaCode	720
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	680-0808
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3054587	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1157413	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1420200	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2851538	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2904741	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1175809	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	637680	usd
CY2023Q1	GBCS	Employee Retention Credits Receivable EmployeeRetentionCreditsReceivable	6350533	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	11535293	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4962621	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1042330	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	996400	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	35057898	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	35454113	usd
CY2023Q1	us-gaap	Goodwill Goodwill	1076908	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1076908	usd
CY2023Q1	us-gaap	Assets Assets	48712429	usd
CY2022Q4	us-gaap	Assets Assets	42490042	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5228731	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3644001	usd
CY2023Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	8100	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	7500	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	180055	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	257222	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	3933555	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2296830	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	10070386	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6848331	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	536542	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	553775	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	33378644	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	34397488	usd
CY2023Q1	us-gaap	Security Deposit Liability SecurityDepositLiability	292888	usd
CY2022Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	291388	usd
CY2023Q1	us-gaap	Liabilities Liabilities	43741918	usd
CY2022Q4	us-gaap	Liabilities Liabilities	41537207	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3054587	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3054587	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3054587	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3054587	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	152728	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	152728	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13768300	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13768300	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9726517	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13744193	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4970511	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	952835	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	48712429	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42490042	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9605671	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10091006	usd
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	8509271	usd
CY2022Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	6961903	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2204846	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1811517	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	423180	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	253963	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	438730	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	447687	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	11576027	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	9475070	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1970356	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	615936	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-46466	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	518299	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	382312	usd
CY2023Q1	GBCS	Income From Employee Retention Credits IncomeFromEmployeeRetentionCredits	6350533	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	163298	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	41521	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5995532	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-387257	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4025176	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	228679	usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	7500	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4017676	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	228679	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.32
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.32
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3054587	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3052769	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3054587	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3052769	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	952835	usd
CY2023Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	7500	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4025176	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4970511	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3102182	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3102182	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	255000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	46466	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	228679	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3632327	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3632327	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4025176	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	228679	usd
CY2022Q1	GBCS	Other Income From Partial Settlement Of Debt OtherIncomeFromPartialSettlementOfDebt	40346	usd
CY2023Q1	GBCS	Other Income From Adjustment Of Debt OtherIncomeFromAdjustmentOfDebt	50000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	438730	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	447687	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	94398	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	423180	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	253963	usd
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	369977	usd
CY2022Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	915516	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-135801	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-108059	usd
CY2023Q1	GBCS	Increase Decrease In Employee Retention Credit Receivables IncreaseDecreaseInEmployeeRetentionCreditReceivables	-6350533	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1584730	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1305551	usd
CY2023Q1	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	1500	usd
CY2022Q1	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	5499	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-66995	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1217526	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	42515	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	64192	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-42515	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-64192	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	501006	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	-601453	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	-353811	usd
CY2023Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	6900	usd
CY2022Q1	GBCS	Proceeds From Debt Discount Warrants Related Parties ProceedsFromDebtDiscountWarrantsRelatedParties	46466	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-107347	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-307345	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-216857	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1589063	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2416600	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4793101	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2199743	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3204038	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	423900	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	382312	usd
CY2023Q1	us-gaap	Cash Cash	1157413	usd
CY2022Q1	us-gaap	Cash Cash	2310526	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1042330	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	893512	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2199743	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3204038	usd
CY2023Q1	GBCS	Dividends Declared On Series D Preferred Stock DividendsDeclaredOnSeriesDPreferredStock	7500	usd
CY2022Q1	GBCS	Dividends Declared On Series D Preferred Stock DividendsDeclaredOnSeriesDPreferredStock	7500	usd
CY2023Q1	GBCS	Financing Of Insurance Premiums FinancingOfInsurancePremiums	673930	usd
CY2022Q1	GBCS	Financing Of Insurance Premiums FinancingOfInsurancePremiums	581393	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-66995	usd
CY2023Q1	GBCS	Working Capital Deficit WorkingCapitalDeficit	-1300000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4025176	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	228679	usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	7500	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4017676	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	228679	usd
CY2023Q1	GBCS	Net Income Loss Attributable To Diluted Gross NetIncomeLossAttributableToDilutedGross	4025176	usd
CY2022Q1	GBCS	Net Income Loss Attributable To Diluted Gross NetIncomeLossAttributableToDilutedGross	228679	usd
CY2023Q1	GBCS	Preferred Stock Dividends And Other Adjustments Diluted PreferredStockDividendsAndOtherAdjustmentsDiluted	7500	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	4017676	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	228679	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3054587	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3052769	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	3054587	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	3052769	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3054587	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3052769	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.32
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.32
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49268879	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49226364	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12650981	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12212251	usd
CY2023Q1	GBCS	Impairment Impairment	1560000	usd
CY2022Q4	GBCS	Impairment Impairment	1560000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	35057898	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	35454113	usd
CY2023Q1	us-gaap	Depreciation Depreciation	438730	usd
CY2022Q1	us-gaap	Depreciation Depreciation	447687	usd
CY2023Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	38928797	usd
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	38405315	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	716598	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	810997	usd
CY2023Q1	GBCS	Debt Longterm And Shortterm Combined Net Amount DebtLongtermAndShorttermCombinedNetAmount	38212199	usd
CY2022Q4	GBCS	Debt Longterm And Shortterm Combined Net Amount DebtLongtermAndShorttermCombinedNetAmount	37594318	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	3933555	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2296830	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	33378644	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	34397488	usd
CY2023Q1	us-gaap	Prepaid Expense Other Noncurrent PrepaidExpenseOtherNoncurrent	146740	usd
CY2022Q1	us-gaap	Prepaid Expense Other Noncurrent PrepaidExpenseOtherNoncurrent	177716	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	476784	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	643401	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	651954	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	660665	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	55116	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2487920	usd
CY2023Q1	GBCS	Income From Employee Retention Credits IncomeFromEmployeeRetentionCredits	6350533	usd

Files In Submission

Name	View Source	Status
0001493152-23-027086-index-headers.html	Edgar Link	pending
0001493152-23-027086-index.html	Edgar Link	pending
0001493152-23-027086.txt	Edgar Link	pending
0001493152-23-027086-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
gbcs-20230331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
gbcs-20230331_cal.xml	Edgar Link	unprocessable
gbcs-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
gbcs-20230331_def.xml	Edgar Link	unprocessable
gbcs-20230331_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GBCS
SELECTIS HEALTH, INC. Stock $gbcs

2023 Q1 Form 10-Q Financial Statement

#000149315223027086 Filed on August 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GBCS SELECTIS HEALTH, INC. Stock $gbcs

2023 Q1 Form 10-Q Financial Statement

#000149315223027086 Filed on August 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GBCS
SELECTIS HEALTH, INC. Stock $gbcs